NIH HEAL Initiative
Overview
NIH HEAL Initiative is a trans-NIH effort to speed scientific solutions to stem the national opioid public health crisis by improving prevention and treatment for opioid misuse and addiction and enhancing pain management.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Adolore Biotherapeutics, Inc. | Oct 2023 | Grant | Co-investor |
| InterveXion | Sep 2022 | Grant | Co-investor |
| Navega Therapeutics | Sep 2019 | Grant | Co-investor |
Key People
Nananda Col
Founder, Shared Decision Making Resources
Bridget Lampert
Managing Director, NIH Oxford Cambridge Scholars Program And MDPhD Program
Kristi M. Porter
Managing Director, NIH Oxford-Cambridge Scholars Program
Kris Walker
Clinical Research Partner
Christian Grillon
Principal Investigator
Dan Benjamini
Principal Investigator. Chief, Multiscale Imaging And Integrative Biophysics Unit, NIA
David McDermott
Principal Investigator
Dhruba Chattoraj
Sr. Principal Investigator
Dianne Thorpe
Principal Administrative Officer
Doris Wu
Principal Investigator
Emmanouil Maragkakis
Stadtman Principal Investigator & Chief Of Computational Genomics Unit
Ernie Pedapati
Principal Investigator (NIMH R01)
Gene Teveler
Principal Enterprise Architect
Ghazala Ashfaq
Principal
Jian Liu
Principal Investigator
John Coligan
Principal Investigator
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
